ML407

• CAT Number: I032427
• CAS Number: 701940-94-5
• Molecular Formula: C19H22N2OS
• Molecular Weight: 326.45
• Purity: 98%
• Synonyms: ML407; ML-407; ML 407
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 3-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]-1H-benzimidazole-2-thione
• InChI: InChI=1S/C19H22N2OS/c1-13(2)15-9-8-14(3)12-18(15)22-11-10-21-17-7-5-4-6-16(17)20-19(21)23/h4-9,12-13H,10-11H2,1-3H3,(H,20,23)
• InChIKey: FEHKMRKXIVBAPE-UHFFFAOYSA-N
• SMILES: CC1=CC(=C(C=C1)C(C)C)OCCN2C3=CC=CC=C3NC2=S

ML407（Cat No.:I032427）is a small molecule compound being studied for its potential therapeutic applications, particularly in the treatment of neurological disorders. It functions as a selective inhibitor of a specific target protein, which plays a role in various cellular processes such as cell signaling and neurotransmission. By modulating these pathways, ML407 may offer therapeutic benefits in conditions related to cognitive dysfunction, neurodegeneration, and other neurological diseases. Research is ongoing to assess the compound’s efficacy, safety, and pharmacokinetics, with the goal of developing it as a potential treatment for conditions like Alzheimer’s disease or Parkinson’s disease.